The Death of the Data Warehouse

Posted by ZS Editors on Thu, Sep 28, 2017

Traditional data warehouses have limited utility in today’s healthcare ecosystem because they often can’t process the types of unstructured data that give pharmaceutical organizations a competitive edge. Rigid data storage systems and old-school modeling no longer cut it. Pharmaceutical firms need a modern data infrastructure that’s capable of handling structured and unstructured data, sufficiently scalable and technologically able to support advanced analytics, resulting in actionable insights that can enable commercial teams to make data-driven decisions in real time. 


>
Read More

Four MDM Trends From Informatica World

Posted by Mahmood Majeed on Mon, Jun 05, 2017

Ammar Feroz co-wrote this blog post with Mahmood Majeed.

While data and analytics have been top-of-mind issues in life sciences for many years, master data management, in particular, was one of the most talked-about issues at this year’s Informatica World summit, held May 15-18 in San Francisco.


>
Read More

Three Analytics Lessons From the Tennis Match-Fixing Scandal

Posted by Howard Deutsch on Fri, Jan 29, 2016

If you’re even just a casual tennis fan like me, then you’ve seen the report of a major scandal brewing on the professional tour. A joint investigation by BuzzFeed and the BBC cheekily called “The Tennis Racket” has purportedly uncovered evidence of widespread match-fixing. While the story, itself, is sensational, I’m particularly interested in three very important lessons that we can learn from this alleged betting scandal about getting it right with analytics.


>
Read More

Data Analytics Give Oncology Products Competitive Edge

Posted by Maria Whitman on Tue, Mar 24, 2015

Recent launches have proven that having a great product isn’t enough. To succeed in the oncology market, pharmaceutical and biotech companies must be able to understand performance and opportunities, and explain the difference for increasingly specific patient populations. Data has come a long way, and integrated data analytics is a powerful way to surface and interpret an oncology product’s opportunity amid brutal competition.


>
Read More

Oncology Company Overcomes Market’s High Hurdles With New Analytics Platform

Posted by Mahmood Majeed on Mon, Feb 16, 2015

With annual sales predicted to soon surpass $100 billion, oncology drugs represent a huge opportunity. The sales and marketing challenge, as the following case study reveals, is to understand consumer preferences and decision-making within the complexities of cancer treatment. Predictive analytics are essential.


>
Read More